SLC7A11 and lung carcinoma: As a key regulator of ferroptosis, the inhibition of SLC7A11 translation can induce ferroptosis, and when the SLC7A11 is upregulated, ferroptosis is inhibited, which is not conducive to lung cancer treatment [2, 42].